GOOD NEWS! The COVID-19 (SARS-CoV-2) Antigen Rapid Tests (Nasal Swab and Oral Fluid) independently developed by HANGZHOU ALLTEST BIOTECH CO.,LTD. have successfully passed the approval of Therapeutic Goods Administration Certificate to enter the Australian market means that the quality of ALLTEST BIOTECH SARS-CoV-2 antigen rapid test kits are highly recognized and trusted by TGA.
ALLTEST COVID-19 Antigen Rapid Test Offers:
Easy Nasal Swab and Oral Fluid specimen collection
Fast results in 15 minutes assay time
Easy visually interpretation
Simple operation, no equipment required
As the current epidemic situation at home and abroad is still very severe, ALLTEST BIOTECH will continue to research and development rapid test products of the COVID-19 and contribute to the fight against the COVID-19 epidemic.
TGA: The Therapeutic Goods Administration (TGA) is Australia's regulatory authority for therapeutic goods. We carry out a range of assessment and monitoring activities to ensure therapeutic goods available in Australia are of an acceptable standard with the aim of ensuring that the Australian community has access, within a reasonable time, to therapeutic advances.
Contact Person: Mrs. Selina
Tel: +86 13989889852